Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis

Por Martin, B, Paesmans, M, Mascaux, C, Berghmans, T, Lothaire, P, Meert, A-P, Lafitte, J-J, Sculier, J-P
Publicado em 2004

The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis

Por Meert, A-P, Paesmans, M, Martin, B, Delmotte, P, Berghmans, T, Verdebout, J-M, Lafitte, J-J, Mascaux, C, Sculier, J-P
Publicado em 2002

The role of HER-2/neu expression on the survival of patients with lung cancer: a systematic review of the literature

Por Meert, A-P, Martin, B, Paesmans, M, Berghmans, T, Mascaux, C, Verdebout, J-M, Delmotte, P, Lafitte, J-J, Sculier, J-P
Publicado em 2003

Has Cox-2 a prognostic role in non-small-cell lung cancer? A systematic review of the literature with meta-analysis of the survival results

Por Mascaux, C, Martin, B, Paesmans, M, Berghmans, T, Dusart, M, Haller, A, Lothaire, P, Meert, A-P, Lafitte, J-J, Sculier, J-P
Publicado em 2006

The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis

Por Mascaux, C, Iannino, N, Martin, B, Paesmans, M, Berghmans, T, Dusart, M, Haller, A, Lothaire, P, Meert, A-P, Noel, S, Lafitte, J-J, Sculier, J-P
Publicado em 2005

The role of mitomycin in the treatment of non-small cell lung cancer: a systematic review with meta-analysis of the literature

Por Sculier, J P, Ghisdal, L, Berghmans, T, Branle, F, Lafitte, J J, Vallot, F, Meert, A P, Lemaitre, F, Steels, E, Burniat, A, Mascaux, C, Paesmans, M
Publicado em 2001

Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis

Por Martin, B, Paesmans, M, Berghmans, T, Branle, F, Ghisdal, L, Mascaux, C, Meert, A-P, Steels, E, Vallot, F, Verdebout, J-M, Lafitte, J-J, Sculier, J-P
Publicado em 2003

Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell...

Por Sculier, J-P, Lafitte, J-J, Paesmans, M, Thiriaux, J, Alexopoulos, C G, Baumöhl, J, Schmerber, J, Koumakis, G, Florin, M C, Zacharias, C, Berghmans, T, Mommen, P, Ninane, V, Klastersky, J
Publicado em 2000

Second-line paclitaxel in non-small cell lung cancer initially treated with cisplatin: a study by the European Lung Cancer Working Party

Por Berghmans, T, Lafitte, J J, Lecomte, J, Alexopoulos, C G, Van Cutsem, O, Giner, V, Efremidis, A, Berchier, M C, Collon, T, Meert, A P, Scherpereel, A, Ninane, V, Leclercq, N, Paesmans, M, Sculier, J P
Publicado em 2007

A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor o...

Por Sculier, J P, Paesmans, M, Lecomte, J, Van Cutsem, O, Lafitte, J J, Berghmans, T, Koumakis, G, Florin, M C, Thiriaux, J, Michel, J, Giner, V, Berchier, M C, Mommen, P, Ninane, V, Klastersky, J
Publicado em 2001

Pharmacokinetic profile of ABELCET (amphotericin B lipid complex injection): combined experience from phase I and phase II studies.

Por Adedoyin, A, Bernardo, J F, Swenson, C E, Bolsack, L E, Horwith, G, DeWit, S, Kelly, E, Klasterksy, J, Sculier, J P, DeValeriola, D, Anaissie, E, Lopez-Berestein, G, Llanos-Cuentas, A, Boyle, A, Branch, R A
Publicado em 1997